Minna Valtavaara

581 total citations
10 papers, 470 citations indexed

About

Minna Valtavaara is a scholar working on Molecular Biology, Rheumatology and Genetics. According to data from OpenAlex, Minna Valtavaara has authored 10 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Rheumatology and 3 papers in Genetics. Recurrent topics in Minna Valtavaara's work include Microbial metabolism and enzyme function (5 papers), Connective tissue disorders research (3 papers) and Folate and B Vitamins Research (3 papers). Minna Valtavaara is often cited by papers focused on Microbial metabolism and enzyme function (5 papers), Connective tissue disorders research (3 papers) and Folate and B Vitamins Research (3 papers). Minna Valtavaara collaborates with scholars based in Finland, Belgium and South Africa. Minna Valtavaara's co-authors include Raili Myllylä, Claude Szpirer, Josiane Szpirer, Chunguang Wang, Anna Maria Pirttilä, Heli Helander, Maija Risteli, Jaana Latvala, Jari Heikkinen and Mart Ustav and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Vaccine.

In The Last Decade

Minna Valtavaara

10 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minna Valtavaara Finland 9 313 194 123 109 71 10 470
Fritz Costa United States 8 241 0.8× 192 1.0× 160 1.3× 34 0.3× 37 0.5× 9 482
Wilma Vree Egberts Netherlands 11 509 1.6× 54 0.3× 229 1.9× 74 0.7× 28 0.4× 18 744
Steven B. Ludbrook United Kingdom 10 367 1.2× 59 0.3× 126 1.0× 197 1.8× 59 0.8× 11 669
Dirk Carstanjen Germany 11 295 0.9× 173 0.9× 32 0.3× 20 0.2× 27 0.4× 13 503
Paul S. Kaytes United States 13 237 0.8× 69 0.4× 66 0.5× 12 0.1× 74 1.0× 15 438
Helena Pulyaeva United States 11 253 0.8× 44 0.2× 46 0.4× 119 1.1× 141 2.0× 15 583
S. K. Libutti United States 9 265 0.8× 99 0.5× 18 0.1× 9 0.1× 73 1.0× 15 509
Maria Rosa Lidonnici Italy 16 448 1.4× 204 1.1× 32 0.3× 21 0.2× 64 0.9× 32 954
Joshua W. Collins United States 7 337 1.1× 72 0.4× 71 0.6× 6 0.1× 71 1.0× 12 571
Leon Carayannopoulos United States 8 357 1.1× 52 0.3× 35 0.3× 57 0.5× 41 0.6× 10 635

Countries citing papers authored by Minna Valtavaara

Since Specialization
Citations

This map shows the geographic impact of Minna Valtavaara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minna Valtavaara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minna Valtavaara more than expected).

Fields of papers citing papers by Minna Valtavaara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minna Valtavaara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minna Valtavaara. The network helps show where Minna Valtavaara may publish in the future.

Co-authorship network of co-authors of Minna Valtavaara

This figure shows the co-authorship network connecting the top 25 collaborators of Minna Valtavaara. A scholar is included among the top collaborators of Minna Valtavaara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minna Valtavaara. Minna Valtavaara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vardas, Eftyhia, Mika Leinonen, Kim Ellefsen, et al.. (2012). Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects. Vaccine. 30(27). 4046–4054. 32 indexed citations
2.
Blazevic, Vesna, Andres Männik, Maria Malm, et al.. (2006). Induction of Human Immunodeficiency Virus Type-1-Specific Immunity with a Novel Gene Transport Unit (GTU)-MultiHIV DNA Vaccine. AIDS Research and Human Retroviruses. 22(7). 667–677. 24 indexed citations
3.
Fujiwara, Kôsaku, et al.. (2002). A Single-Chain Antibody/Epitope System for Functional Analysis of Protein−Protein Interactions. Biochemistry. 41(42). 12729–12738. 12 indexed citations
4.
Wang, Chunguang, Minna Valtavaara, & Raili Myllylä. (2000). Lack of Collagen Type Specificity for Lysyl Hydroxylase Isoforms. DNA and Cell Biology. 19(2). 71–77. 28 indexed citations
5.
Heikkinen, Jari, Maija Risteli, Chunguang Wang, et al.. (2000). Lysyl Hydroxylase 3 Is a Multifunctional Protein Possessing Collagen Glucosyltransferase Activity. Journal of Biological Chemistry. 275(46). 36158–36163. 115 indexed citations
6.
Valtavaara, Minna, Claude Szpirer, Josiane Szpirer, & Raili Myllylä. (2000). Primary structure, tissue distribution, and chromosomal localization of a novel isoform of lysyl hydroxylase (lysyl hydroxylase 3).. Journal of Biological Chemistry. 275(27). 20956–20956. 7 indexed citations
7.
Valtavaara, Minna. (1999). Novel lysyl hydroxylase isoforms. 11 indexed citations
8.
Valtavaara, Minna, Claude Szpirer, Josiane Szpirer, & Raili Myllylä. (1998). Primary Structure, Tissue Distribution, and Chromosomal Localization of a Novel Isoform of Lysyl Hydroxylase (Lysyl Hydroxylase 3). Journal of Biological Chemistry. 273(21). 12881–12886. 105 indexed citations
9.
Valtavaara, Minna, et al.. (1997). Cloning and Characterization of a Novel Human Lysyl Hydroxylase Isoform Highly Expressed in Pancreas and Muscle. Journal of Biological Chemistry. 272(11). 6831–6834. 115 indexed citations
10.
Szpirer, Claude, et al.. (1997). Localization of the gene encoding a novel isoform of lysyl hydroxylase. Mammalian Genome. 8(9). 707–708. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026